Lafeuillade Alain
Department of Infectious Diseases, General Hospital, Toulon, France.
HIV Clin Trials. 2011 May-Jun;12(3):121-30. doi: 10.1310/hct1203-121.
Despite long-term viral suppression with antiretroviral therapy (ART), HIV persists in reservoirs and sanctuary sites. Lifelong therapy is therefore necessary, leading to problems of compliance, toxicity, and cost. Over the last few years, important advances have been made in our understanding of the composition and the maintenance mechanisms of the HIV reservoir. Although complete viral eradication is currently out of reach, a growing number of scientists think that a "functional" cure is achievable. This situation would combine no disease progression, no virus transmission, and a life expectancy close to uninfected individuals in the absence of ART. At acute HIV infection, ART increases the frequency of sustained viremia control after its discontinuation, compared with the natural history of untreated disease. For patients at the chronic stage of HIV infection, ART alone is insufficient to clear viral reservoirs and new molecules intended to purge this reservoir or gene therapy approaches are warranted. This search for a cure needs innovation, audaciousness, and coordination. It also needs political, institutional, and private commitments for funding, which by now are severely lacking.
尽管抗逆转录病毒疗法(ART)可实现长期病毒抑制,但HIV仍存在于储存库和庇护所部位。因此,终身治疗是必要的,这导致了依从性、毒性和成本等问题。在过去几年中,我们对HIV储存库的组成和维持机制的理解取得了重要进展。尽管目前完全根除病毒尚无法实现,但越来越多的科学家认为“功能性”治愈是可以实现的。这种情况将在不进行ART的情况下,实现无疾病进展、无病毒传播,且预期寿命接近未感染个体。在急性HIV感染时,与未治疗疾病的自然病程相比,ART可提高停药后持续病毒血症控制的频率。对于处于HIV感染慢性阶段的患者,仅靠ART不足以清除病毒储存库,因此需要新的分子来清除该储存库或采用基因治疗方法。这种治愈方法的探索需要创新、大胆和协调。它还需要政治、机构和私人在资金方面的承诺,而目前这些承诺严重不足。